| |
|
|
|
ProQR Therapeutics N.V.  
|
|
4.99 0.01 (0%) |
07-10 16:00 |
|
Open: |
5.02 |
Pre close: |
4.98 |
Target:
|
7.24 
|
|
High: |
5.2135 |
Low: |
4.91 |
Resistance:
|
6.20
7.00
|
|
Volume: |
129,526 |
Market Cap: |
249M |
Support:
|
4.91
4.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.22
|
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
5.82 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
5.88 |
Stochastic Oscillator |
%K(14,3):
|
3.89  |
|
MA(250): |
7.09 |
%D(3): |
5.60 |
|
Average Volume(K) |
3-Month: |
14519
|
52-Week |
High:
|
10.98 |
|
10-Days: |
12659 |
Low: |
4.46 |
|
RSI |
RSI(14):
|
35.30 |
Change(%): |
-44.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.310 |
Return on Equity (ttm) |
-72.3 |
Shares Out. (M) |
49.97 |
|
EPS Est. Current Year |
-2.110 |
Return on Assets (ttm) |
-36.0 |
Shares Float (M) |
37.06 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.56 |
|
EPS Est. Next Quarter |
-0.520 |
Qtrly Rev. Growth |
-36.8 |
% Held by Institutions |
74.08 |
|
Forward EPS |
-1.241 |
Gross Profit (p.s.) |
0.039 |
Shares Short (K) |
397 |
|
Book Value (p.s.) |
3.090 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.61 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
